Madrigal Pharmaceuticals Inc (MDGL)
EBITDA Margin
-13.62%
Quarterly · Period ending:
MDGL EBITDA Margin
Latest reported-13.62%period ending
Latest reported-13.62%period ending
MDGL Quarterly EBITDA Margin (-3151.45% → -13.62%)
Quarterly ebitda margin
High-resolution chart · PNG
MDGL ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -13.6219% | |
| -27.6825% | |
| -15.5368% | |
| -37.032% | |
| -18.1577% | |
| -50.6827% | |
| -53.7689% | |
| -165.6405% | |
| -1,011.395% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -236.4932% | |
| 0% | |
| 0% | |
| -9,751.7007% | |
| -290.6223% | |
| -713.2212% | |
| -858.5672% | |
| -920.9974% | |
| -195.7394% | |
| -288.4422% | |
| -254.8214% | |
| -217.3254% | |
| -138.141% | |
| 90.6192% | |
| -167.7849% | |
| -476.8514% | |
| -3,959.5912% | |
| -2,022.1698% | |
| -1,668.0867% | |
| -1,327.8774% | |
| -2,081.2921% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -3,151.4451% |